ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 681639 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 681639; 2) Community: the network communities that were significantly associated with the response to NSC 681639; 3) Molecule: the relationships between components within communities and NSC 681639; 4) MDR: the compounds that were significantly associated with the NSC 681639.

NSC Compound Enrichment Correlation
NSC 354051 LISCUNDITRIN 0.0133299224082803 0.017465784
NSC 625603 Null 0.0133299224082803 0.30350962
NSC 629971 Camptothecin Derivative 0.0133299224082803 0.90165461
NSC 645017 1,4-bis[(2-Aminoethyl)amino]-5,8-dihydroxyanthraquinone 0.0133299224082803 0.7902421
NSC 659687 6H-Pyrido[4,3-b]carbazole-1-carboxamide, 9-hydroxy- 5,6-dimethyl-N-[2-(dimethylamino)ethyl]-, dihydrochloride 0.0133299224082803 0.70630846
NSC 664217 Null 0.0133299224082803 0.20217254
NSC 669268 (2S,3S)-2-Hydroxy-2-phenyl-3-p-tolylsulfenylbutanamide 0.0133299224082803 0.10728593
NSC 355457 11H-Indeno[1,2-c]isoquinolinium, 9-hydroxy-2,3,8-trimethoxy-6-methyl-, chloride 0.0139796580235792 0.76226704
NSC 690248 Null 0.0139796580235794 0.074654837
NSC 111533 Methoxycamptothecin 0.0171439890681608 0.82556973
Total:56  Current:22    [First] [Prev] [Next] [Last]